PFAS Alternatives in Medicines Report

A report by the University of Freiburg, commissioned by the Germany — German Environment Agency, reveals that many PFAS-based active ingredients in human and veterinary medicines can be replaced by alternatives. The study, led by Professor Michael Müller, found that PFAS-free options exist for 87% of human medicines and 65% of veterinary medicines containing PFAS structures. These findings suggest that per- or polyfluorination is not strictly necessary for the medical effect and highlight the environmental burden of PFAS, which can break down into toxic substances like trifluoroacetic acid (TFA). The Germany — German Environment Agency, under President Dr. Dirk Messner, is integrating this data into its Environmental Pharmaceutical Index to guide doctors and pharmacists. The report is also relevant to the European Union — European Chemicals Agency's ongoing assessment of an EU-wide PFAS restriction, potentially influencing a legislative proposal from the International — European Commission in 2027, which could remove the current exemption for active pharmaceutical ingredients.